Clinical Trial Update: Study to Evaluate Efficacy and Safety of Switching From TDF to TAF in Adults With Chronic Hepatitis B Who Are Virologically Suppressed [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of switching virologically suppressed chronic hepatitis B patients from TDF to TAF. Completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Tenofovir alafenamide (TAF) (Tenofovir alafenamide)
• tenofovir disoproxil fumarate (TDF) (tenofovir disoproxil fumarate)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Hepatitis B | Phase 3 | Status: COMPLETED | Results posted: 2019-09-25